Stock Performance and Market Context
On 13 Mar 2026, Evexia Lifecare’s share price fell by 4.14% during the trading session, underperforming its sector by 3.29%. The stock is currently trading below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. This decline comes in the backdrop of a broader market sell-off, with the Nifty closing at 23,151.10, down 488.05 points or 2.06%. Several indices, including Nifty Media, Nifty Realty, and S&P Bse Dollex 30, also hit new 52-week lows on the same day, reflecting widespread market pressure.
Evexia Lifecare’s 52-week high was Rs.3.04, indicating a steep fall of approximately 54.9% from its peak over the past year. The stock’s one-year performance stands at a negative 45.70%, contrasting sharply with the Sensex’s modest 1.00% gain over the same period. This underperformance extends beyond the last year, with the stock lagging the BSE500 index across one year, three months, and three years.
Financial and Operational Metrics
Evexia Lifecare’s financial indicators reveal challenges in sustaining growth and profitability. The company has experienced a compound annual growth rate (CAGR) decline of 23.63% in operating profits over the last five years. Its ability to service debt is constrained, as reflected by a Debt to EBITDA ratio of -1.00 times, indicating a negative EBITDA relative to debt levels. Return on Equity (ROE) averages a low 0.88%, signalling limited profitability generated per unit of shareholders’ funds.
The company reported flat results in the quarter ending December 2025, further underscoring the subdued earnings trajectory. Profitability has deteriorated significantly, with profits falling by 60.3% over the past year. Return on Capital Employed (ROCE) is minimal at 0.1%, while the enterprise value to capital employed ratio stands at 0.8, suggesting a fair valuation relative to the capital base.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Shareholding and Market Capitalisation
Evexia Lifecare is classified as a micro-cap stock, with majority shareholding held by non-institutional investors. This ownership structure may influence liquidity and trading patterns. The stock’s Mojo Score is 20.0, with a Mojo Grade of Strong Sell as of 28 Apr 2025, upgraded from a previous Sell rating. This grading reflects the company’s weak long-term fundamentals and ongoing challenges in financial performance.
Technical Indicators
Technical analysis presents a mixed picture. On the weekly timeframe, the MACD and KST indicators show mild bullish signals, but monthly readings for both are bearish. Bollinger Bands indicate bearish trends on both weekly and monthly charts. The Relative Strength Index (RSI) offers no clear signal on either timeframe. Daily moving averages remain bearish, while Dow Theory assessments suggest mild bearishness weekly and monthly. Overall, technicals align with the downward price movement observed in recent months.
Sector and Market Environment
The edible oil sector, to which Evexia Lifecare belongs, has faced headwinds amid broader market declines. The Nifty Midcap 100 index, a key benchmark for mid-sized companies, fell by 2.65%, dragging the market lower. Evexia’s underperformance relative to its sector and indices highlights sector-specific pressures compounded by company-specific factors.
Holding Evexia Lifecare Ltd from Edible Oil? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Valuation and Comparative Analysis
Despite the weak performance, Evexia Lifecare’s stock is trading at a discount relative to its peers’ average historical valuations. The enterprise value to capital employed ratio of 0.8 suggests the market is pricing the company conservatively. However, the low ROCE and profitability metrics indicate limited capital efficiency. The stock’s valuation reflects the market’s cautious stance given the company’s financial profile and recent price trends.
Summary of Key Metrics
To summarise, Evexia Lifecare Ltd’s stock has declined to Rs.1.37, its lowest level in 52 weeks, amid a challenging market and sector environment. The company’s financial indicators reveal subdued growth, low profitability, and constrained debt servicing capacity. Technical signals predominantly point to bearish trends, while valuation metrics suggest the stock is trading at a discount but with limited upside given fundamentals. The stock’s underperformance relative to major indices and sector peers underscores the difficulties faced over the past year.
Market Sentiment and Outlook
Market sentiment towards Evexia Lifecare remains cautious, as reflected in the Mojo Grade of Strong Sell and the stock’s persistent decline below key moving averages. The broader market weakness and sectoral pressures have compounded the stock’s downward trajectory. Investors and analysts will continue to monitor the company’s financial results and market developments closely.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
